EC Number: 689-178-4
Chemical Formula: C₅₄H₆₉N₁₁O₁₀S₂
CAS Number: 108736-35-2
IUPAC Name: (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p
Molecular Weight: 1096.3
Titre (Assay): Pureté ≥98,0 % ; masse moléculaire d'environ 1096,32 g/mol (C54H69N11O10S2)
Profil d'impuretés: Conforme aux limites d'impuretés pharmacopéiques/alignées ICH ; substances apparentées contrôlées individuellement

Autres informations

Description supplémentaire:

Lanreotide (CAS 108736-35-2) has the sequence {D-2Nal}-Cys-Tyr-{D-Trp}-Lys-Val-Cys-Thr-NH2 with a disulfide bond between Cys2 and Cys7, a molecular formula of C54H69N11O10S2, a molecular weight of 1096.32336 g/mol, and purity ≥98.0%. It is mainly used to manage acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome.